Neurology

Singing River Neurology has developed a multidisciplinary team of medical professionals who provide expertise in evaluating, developing, and implementing a customized treatment plan for each patient. We specialize in nerve conduction studies and EMGs.

Neurological Conditions We Treat

Our neuroscience team possesses the expertise to help you with a wide array of neurological conditions/diseases including:

• Stroke
• Dementia and Alzheimer’s disease
• Movement disorders
• Parkinson’s disease
• Sciatica
• Vertigo
• Tingling
• Migraine (therapeutic botox available)
• Multiple sclerosis

Neuro Intensive Care Unit

Our Neuroscience Team is on call 24/7 and is supported by our dedicated 8-bed Neuro Intensive Care Unit.

Comprehensive Rehabilitation Center (CRC)

Our patients receive comprehensive medical rehab in our inpatient CRC, located at Pascagoula Hospital. At the CRC, we help these patients recover and regain mobility and function lost due to strokes, neurological disorders, and other debilitating conditions.

Sleep Disorders

At the Neuroscience Center, we do a sleep evaluation to determine whether a patient would benefit from an overnight Sleep Study. These sleep studies help us diagnose and treat a number of sleep disorders like Sleep Apnea, Restless Leg Syndrome, Insomnia, Narcolepsy, and many more.

Our goal is to enhance each patient’s quality of life by decreasing their pain, restoring function, and creating a treatment plan that enables them to return to the daily activities they enjoy.

Neurology Support Groups

Support groups are held in the Neuroscience center for Aphasia Communication, Lymphedema Risk Awareness, Movement Disorder Exercise, Parkinson’s Disease, and Stroke. See more about these groups and their meeting times.

Accreditations

Singing River has received the American Heart Association/American Stroke Association’s Get With The Guidelines® Target: Stroke Honor Roll Elite Gold Plus Quality Achievement Award given to hospitals with a low “door to needle” time from patient arrival to treatment with clot-busting tissue plasminogen activator, or tPA — the only FDA-approved treatment for ischemic stroke.